Rohm and Haas to increase prices
๐
Article
๐
2003
๐
Elsevier Science
โ 31 KB
R&D costs rose by 5% to DKR 713 M for 2002. The group generated profit of DKR 644 M after tax for 2002. Headquartered in Denmark, Novozymes A/S is a biotech-based world leader in enzymes and microorganisms for industrial use. Novozymes also applies its core competences in selected pharmaceutical are